RKDA logo

ARCADIA BIOSCIENCES INC

RKDANASDAQ
๐Ÿ† #5482 by market capEarnings Nov 5US Equity
$0.27โ–ผ $0.03 (โˆ’12.50%)
Live
๐Ÿ””
Track RKDA
Get earnings, price moves & breaking news on Telegram
Track
24hโ–ผ 12.5%
7dโ–ผ 39.6%
14dโ–ผ 37.3%
30dโ–ผ 48.9%
ytdโ–ผ 86.3%
1yโ–ผ 92.0%
๐ŸฆMarket Cap
$417,002
Small Cap
๐Ÿ“ˆRevenue Growth (YoY)
-3.7%
Declining
๐Ÿ“ŠGross Margin
34.6%
Moderate
๐Ÿ’ตFCF Margin
-53.4%
Thin
โš–๏ธP/S Ratio
0.1x
Cheap
Otter Score
56
Weak

Trading Snapshot

Day Range
$0.27 โ€“ $0.27
52-Week Range
$0.28 โ€“ $6.71
Volume
$2.71B
Avg Volume
$2.81B
Shares Outstanding
1.5M
Next Earnings
Oct 25, 2026

Fundamentals Snapshot

Annual Revenue
$5M
Last Q Revenue
$1M
P/E Ratio
-0.0
P/S Ratio
0.1x
EPS (TTM)
$-8.14
Dividend Yield
0.00%
Dilution (1yr)
+0.3%

Why Investors Own RKDA

  • โœ“High-growth profile โ€” revenue up -3.1% YoY with expanding US Equity exposure.
  • โœ“Healthy economics โ€” 66% gross margin and 26% free-cash-flow margin.
  • โœ“New products and segments could unlock additional revenue streams.
โš ๏ธ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

RKDA logo

ARCADIA BIOSCIENCES INC

RKDA
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$5Mโ–ผ โˆ’3.7% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
36.2%โ–ผ โˆ’12.2% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isnโ€™t profitable yet.
โˆ’$10Mโ–ฒ +174.0% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
โˆ’$5Mโ–ผ โˆ’50.9% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing ownerโ€™s slice.
1.4Mโ–ฒ +0.3% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$259Kโ–ผ โˆ’$4M YoY
StockOtter ยท stockotter.space

About ARCADIA BIOSCIENCES INC

Arcadia Biosciences, Inc. is a U.S.-based company that provides plant-derived health and well-being products. Additionally, it is actively engaged in agricultural research and development, with a particular focus on improving wheat crops. The aim of these innovations is to enhance farmers' economic stability by boosting crop performance in the field, increasing their value for food and wellness applications, and expanding their potential for industrial uses. Established in 2002, the company's main office is located in Davis, California.

๐Ÿฆฆ

Otter Score Breakdown

How it's scoredFive components, each rated 1โ€“5โ˜… and equally weighted (20%), averaged to a 0โ€“100 score:๐Ÿ’Ž Quality โ€” gross margin๐Ÿš€ Growth โ€” revenue YoYโš–๏ธ Valuation โ€” P/S ratioโšก Momentum โ€” 30-day price change๐Ÿ’ง Dilution โ€” 1-yr share issuance (buybacks score higher)
๐Ÿ’ŽQualityโ˜…โ˜…โ˜…โ˜…โ˜…
๐Ÿš€Growthโ˜…โ˜…โ˜…โ˜…โ˜…
โš–๏ธValuationโ˜…โ˜…โ˜…โ˜…โ˜…
โšกMomentumโ˜…โ˜…โ˜…โ˜…โ˜…
๐Ÿ’งDilutionโ˜…โ˜…โ˜…โ˜…โ˜…
Overall Score
Weak
56/100

Analyst Ratings

โ“˜
Consensus
Buy
7 analysts
Strong Buy2
Buy4
Hold1
Sell0
Strong Sell0
Ratings as of Apr 2026

Latest News & Updates

Defense Worldยท11h ago

Arcadia Biosciences, Inc. (NASDAQ:RKDA) Short Interest Update

Arcadia Biosciences, Inc. (NASDAQ: RKDA - Get Free Report) saw a significant drop in short interest during the month of September. As of September 15th, there was short interest totaling 9,605 shares, a drop of 48.8% fro

Defense Worldยท27d ago

Analyzing Arcadia Biosciences (NASDAQ:RKDA) & Molson Coors Beverage (NYSE:TAP.A)

Molson Coors Beverage (NYSE: TAP.A - Get Free Report) and Arcadia Biosciences (NASDAQ: RKDA - Get Free Report) are both consumer staples companies, but which is the superior business? We will contrast the two companies b

Defense Worldยท27d ago

Arcadia Biosciences (NASDAQ:RKDA) and Kirin (OTCMKTS:KNBWY) Financial Survey

Kirin (OTCMKTS:KNBWY - Get Free Report) and Arcadia Biosciences (NASDAQ: RKDA - Get Free Report) are both consumer staples companies, but which is the better investment? We will compare the two businesses based on the st

GlobeNewsWireยทAug 13

Arcadia Biosciences (RKDA) Announces Second Quarter and First Half 2026 Financial Results and Business Highlights

โ€“ Net cash used in operating activities only $319K in the second quarter โ€“ โ€“ Arcadia closes $4 million private placement; ends second quarter with $4.2 million in cash โ€“ โ€“ July monthly Zola ยฎ sales top $740K; exceed $1 m

Defense WorldยทAug 12

Arcadia Biosciences (NASDAQ:RKDA) versus Diageo (NYSE:DEO) Critical Comparison

Diageo (NYSE: DEO - Get Free Report) and Arcadia Biosciences (NASDAQ: RKDA - Get Free Report) are both consumer staples companies, but which is the better business? We will compare the two companies based on the strength